Skip to Main Content

Top of the morning to you and a fine one, it is. Now that the shortest person has scrambled for the school bus, we are better focused on the task at hand, which is brewing a cup of stimulation and gathering items of interest. Some days simply get off to an easier start than others, yes? On that note, here are some tidbits to help you on your own quest. Hope you have a smashing day and do keep us in mind if something interest suddenly pops up…

Michael Pearson, the former Valeant Pharmaceutical chief executive, has sued the beleaguered drug maker for refusing to pay him more than 3 million company shares that were due last November under the terms of his separation agreement, The Wall Street Journal reports. The breach of contract lawsuit, which you can read here, also argues that Valeant owes him $180,000 in unpaid consulting fees.


Insys Therapeutics, which is under investigation by federal authorities for conspiring to bribe doctors to prescribe its Subsys version of the fentanyl painkiller, hired a new chief executive. Saeed Motahari arrives from Purdue Pharma, where he was chief commercial officer. The moves comes shortly after Insys founder John Kapoor stepped down as chief executive and chairman. A former Insys chief executive was arrested in December as a result of the probe.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!